CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Pharmacotherapy for pulmonary embolism: new anticoagulants
Hun-Gyu Hwang, Yang-Ki Kim
J Korean Med Assoc. 2022;65(7):442-448.   Published online July 10, 2022
DOI: https://doi.org/10.5124/jkma.2022.65.7.442

Excel Download

Pharmacotherapy for pulmonary embolism: new anticoagulants
Journal of the Korean Medical Association. 2022;65(7):442-448   Crossref logo
Link1 Link2 Link3

Anticoagulants in the Management of Pulmonary Embolism
Pulmonary Embolism [Working Title]. 2021;   Crossref logo
Link1

ANTICOAGULANTS: ARE THEY REALLY EFFECTIVE AGAINST PULMONARY EMBOLISM?
InPharma. 1981;308(1):17-18   Crossref logo
Link1 Link2 Link3

New Prospective for the Management of Low-Risk Pulmonary Embolism: Prognostic Assessment, Early Discharge, and Single-Drug Therapy with New Oral Anticoagulants
Scientifica. 2012;2012:1-12   Crossref logo
Link1 Link2 Link3

New Oral Anticoagulants in the Treatment of Pulmonary Embolism: Efficacy, Bleeding Risk, and Monitoring
Thrombosis. 2013;2013:1-11   Crossref logo
Link1 Link2 Link3

Recombinant tissue plasminogen activator vs urokinase in acute pulmonary embolism
Biomedicine & Pharmacotherapy. 1989;43(6):458   Crossref logo
Link1 Link2

Acta. med. scand. supplement 171. On specific treatment of thrombosis & pulmonary embolism with anticoagulants
Tubercle. 1946;27(12):201   Crossref logo
Link1 Link2

Accidental Rivaroxaban Overdose in a Patient with Pulmonary Embolism: Some Lessons for Managing New Oral Anticoagulants
Clinical Medicine Insights: Case Reports. 2015;8:CCRep.S27992   Crossref logo
Link1 Link2 Link3

Transforming and Simplifying the Treatment of Pulmonary Embolism: “Safe Dose” Thrombolysis Plus New Oral Anticoagulants
Lung. 2015;193(3):369-374   Crossref logo
Link1 Link2 Link3

The Role of New Oral Anticoagulants in the Early Discharge of Acute Pulmonary Embolism Patients at Low and Intermediate Risk of Mortality
Chest. 2016;150(4):1151A   Crossref logo
Link1 Link2